Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource

Д. А. Филимонов1, Alexey Lagunin1, Tatyana A. Gloriozova1, А. В. Рудик1, Д. С. Дружиловский1, Pavel V. Pogodin1,2, Vladimir Poroikov1,2
1V. N. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow, Russia
2N. I. Pirogov Russian National Research Medical University, Moscow, Russia

Tóm tắt

Từ khóa


Tài liệu tham khảo

http://www.chemnavigator.com/cnc/products/iRL.asp .

L. Ruddigkeit, L. C. Blum, and J.-L. Reymond, J. Chem. Inf. Model., 53, 56 (2013).

Thomson Reuters Integrity SM , http://integrity.thomson-pharma.com .

A. L. Hopkins, Nat. Chem. Biol., 4, 682 (2008).

R. Morphy and Z. Rankovic, J. Med. Chem., 49, 4961 (2006).

I. M. Kapetanovic, Chem.-Biol. Interact., 171, 165 (2008).

C. G. Wermuth (editor), The Practice of Medicinal Chemistry, Third Edition, Academic Press, San Diego (2008).

C. Hansch, Acc. Chem. Res., 26, 147 (1993).

R. Franke, Theoretical Drug Design Methods, Akademie-Verlag, Berlin (1984), p. 382.

V. V. Avidon, Khim.-Farm. Zh., 8, 22 (1974).

V. V. Avidon and V. S. Arolovich, Nauchno-Tekhnicheskaya Informatsiya, Ser. 2, No. 5, 26 (1975).

V. V. Avidon, V. S. Arolovich, V. G. Blinova, S. P. Kozlova, and A. M. Freidina, Khim.-Farm. Zh., 17, 321 (1983).

V. V. Avidon, V. S. Arolovich, S. P. Kozlova, and L. A. Piruzyan, Khim.-Farm. Zh., 12, No. 5, 88 (1978).

V. V. Avidon, V. S. Arolovich, S. P. Kozlova, and L. A. Piruzyan, Khim.-Farm. Zh., 12, No. 6, 99 (1978).

V. E. Golender and A. B. Rozenblit, Avtomatika i Telemekhanika, 11, 99 (1974).

V. E. Golender and A. B. Rozenblit, Computer Methods for Drug Design [in Russian], Zinatne, Riga (1978).

V. E. Golender and A. B. Rozenblit, Zh. Vses. Khim. Obshch. Im. D. I. Mendeleeva, 25, No. 1, 28 (1980).

A. B. Rozenblit and V. E. Golender, Logic-combinatorial Methods in Drug Design [in Russian], Zinatne, Riga (1984).

L. A. Piruzyan, V. V. Avidon, A. B. Rozenblit, V. S. Arolovich, V. E. Golender, S. P. Kozlova, E. M. Mikhailovskii, and E. G. Gavrishchuk, Khim.-Farm. Zh., 11, 35 (1977).

V. V. Avidon, I. A. Pomerantsev, V. E. Golender, and A. B. Rozenblit, J. Chem. Inf. Comput. Sci., 22, 207 (1982).

V. V. Avidon and L. A. Leksina, Nauchno-Tekhnicheskaya Informatsiya, Ser. 2, No. 3, 22 (1975).

N. Veretennikova, A. Skorova, V. Kudryashova, A. Rozenblit, A. Barkans, Ya. Betinsh, V. Drboglav, L. Gitlina, Ya. Grinfelds, P. Mellis, D. Petersone, and V. Shatokhin, in: F. Chen and G. Schüürmann (editors), Quantitative Structure-Activity Relationships in Environmental Sciences, SETAC, Pensacola (1997), p. 115.

G. M. Barenboim, L. A. Piruzyan, and A. G. Malenkov, Vestn. Akad. Nauk SSSR, No. 2, 50 (1977).

L. A. Piruzyan, A. G. Malenkov, and G. M. Barenboim, Chemical Aspects of Human Activities and Nature Conservation [in Russian], Preprint, Otdel. Inst. Khim. Fiz. Akad. Nauk SSSR, Chernogolovka (1979).

G. M. Barenboim and A. G. Malenkov, Biologically Active Compounds. New Search Principles [in Russian], Nauka, Moscow (1986).

Yu. V. Burov, L. V. Korol'chenko, and V. V. Poroikov, Byull. Vses. Nauchn. Tsentra po Bezopasnosti Biologicheski Aktivnykh Veshchestv, No. 1, 4 (1990).

V. V. Poroikov, D. A. Filimonov, and A. P. Budunova, Nauchno-tekhnicheskaya Informatsiya, Ser. 2, No. 6, 11 (1993).

D. A. Filimonov, V. V. Poroikov, E. I. Karaicheva, R. K. Kazaryan, A. P. Budunova, E. M. Mikhailovskii, A. V. Rudnitskikh, L. V. Goncharenko, and Yu. V. Burov, Eksperimental'naya i Klinicheskaya Farmakologiya, 58, No. 2, 56 (1995).

D. A. Filimonov and V. V. Poroikov, in: M. G. Ford, R. Greenwood, G. T. Brooks, and R. Franke (editors), Bioactive Compound Design: Possibilities for Industrial Use, BIOS Scientific Publishers, Oxford (1996), p. 47.

T. A. Gloriozova, D. A. Filimonov, A. A. Lagunin, and V. V. Poroikov, Khim.-farm. Zh., 32, No. 12, 33 (1998).

A. V. Stepanchikova, A. A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Curr. Med. Chem., 10, 225 (2003).

D. A. Filimonov and V. V. Poroikov, Ros. Khim. Zh., L, No. 2, 66 (2006).

D. A. Filimonov and V. V. Poroikov, in: A. Varnek and A. Tropsha (editors), Chemoinformatics Approaches to Virtual Screening, RSC Publishing, Cambridge (2008), p. 182.

D. A. Filimonov, V. V. Poroikov, T. A. Gloriozova, and A. A. Lagunin, Certificate for the Official Registration of the PASS Computer Program No. 2006613275, September 15, 2006 [in Russian], Federal Service for Intellectual Property, Patents, and Trademarks, Moscow.

D. Filimonov, V. Poroikov, Yu. Borodina, and T. Gloriozova, J. Chem. Inf. Comput. Sci., 39, 666 (1999).

V. V. Poroikov, D. A. Filimonov, Yu. V. Borodina, A. A. Lagunin, and A. Kos, J. Chem. Inf. Comput. Sci., 40, 1349 (2000).

V. A. Trapkov, A. P. Budunova, O. A. Burova, D. A. Filimonov, and V. V. Poroikov, Voprosy Med. Khim., 43, 39 (1997).

A. Geronikaki, V. Poroikov, D. Hadjipavlou-Litina, D. Filimonov, A. Lagunin, and R. Mgonzo, Quant. Struct.-Act. Relat., 18, 16 (1999).

V. V. Poroikov, D. A. Filimonov, W.-D. Ihlenfeldt, T. A. Gloriozova, A. A. Lagunin, Yu. V. Borodina, A.V. Stepanchikova, and M. C. Nicklaus, J. Chem. Inf. Comput. Sci., 43, 228 (2003).

A. Geronikaki, J. Dearden, D. Filimonov, I. Galaeva, T. Garibova, T. Gloriozova, V. Krajneva, A. Lagunin, F. Macaev, G. Molodavkin, V. Poroikov, S. Pogrebnoi, F. Shepeli, T. Voronina, M. Tsitlakidou, and L. Vlad, J. Med. Chem., 47, 2870 (2004).

A. Geronikaki, S. Vasilevsky, D. Hadjipavlou-Litina, A. Lagunin, and V. Poroikov, Khim. Geterotsikl. Soedin., 769 (2006). [Chem. Heterocycl. Compd., 42, 675 (2006)].

A. A. Lagunin, O. A. Gomazkov, D. A. Filimonov, T. A. Gureeva, E. A. Dilakyan, E. V. Kugaevskaya, Yu. E. Elisseeva, N. I. Solovyeva, and V. V. Poroikov, J. Med. Chem., 46, 3326 (2003).

A. A. Geronikaki, A. A. Lagunin, D. I. Hadjipavlou-Litina, P. T. Elefteriou, D. A. Filimonov, V. V. Poroikov, I. Alam, and A. K. Saxena, J. Med. Chem., 51, 1601 (2008).

V. Poroikov, D. Akimov, E. Shabelnikova, and D. Filimonov, SAR QSAR Environ. Res., 12, 327 (2001).

S. A. Kryzhanovskii, R. M. Salimov, A. A. Lagunin, D. A. Filimonov, T. A. Gloriozova, and V. V. Poroikov, Khim.-farm. Zh., 45, No. 10, 25 (2011).

V. Poroikov, D. Filimonov, A. Lagunin, T. Gloriozova, and A. Zakharov, SAR QSAR Environ. Res., 18, 101 (2007).

S. M. Ivanov, A. A. Lagunin, A. V. Zakharov, D. A. Filimonov, and V. V. Poroikov, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 7, 40 (2013).

A. Dalby, J. G. Nourse, W. D. Hounshell, A. K. I. Gushurst, D. L. Grier, B. A. Leland, and J. Laufer, J. Chem. Inf. Comput. Sci., 32, 244 (1992).

A. Lagunin, A. Stepanchikova, D. Filimonov, and V. Poroikov, Bioinformatics, 16, 747 (2000).

A. V. Sadym, A. A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Khim.-farm. Zh., 36, No. 10, 21 (2002).

A. Sadym, A. Lagunin, D. Filimonov, and V. Poroikov, SAR QSAR Environ. Res., 14, 339 (2003).

A. Geronikaki, D. Druzhilovsky, A. Zakharov, and V. Poroikov, SAR QSAR Environ. Res., 19, 27 (2008).

PASS Online, http://www.way2drug.com/passonline .

D. Weininger, J. Chem. Inf. Comput. Sci., 28, 31 (1988).

http://www.chemaxon.com .

http://www.chemspider.com/ .

http://bioinformatics.charite.de/superpred/ .

http://cpi.bio-x.cn/drar/ .

D. Filimonov, A. Lagunin, A. Rudik, D. Druzhilovsky, S. Ivanov, P. Pogodin, and V. Poroikov, in: Abstracts of the 19th European Symposium on Quantitative Structure-Activity Relationships, Vienna, Austria, August 26-30, 2012, p. 60.

C. B-Rao, A. Kulkarni-Almeida, K. V. Katkar, S. Khanna, U. Ghosh, A. Keche, P. Shah, A. Srivastava, V. Korde, K. V. S. Nemmani, N. J. Deshmukh, A. Dixit, M. K. Brahma, U. Bahirat, L. Doshi, R. Sharma, and H. Sivaramakrishnan, Bioorg. Med. Chem., 20, 2930 (2012).

D. Verbanac, S. C. Jain, N. Jain, M. Chand, H. Čipčić Paljetak, M. Matijašić, M. Perić, V. Stepanić, and L. Saso, Bioorg. Med. Chem., 20, 3180 (2012).

A. Kumar, P. Lohan, D. K. Aneja, G. K. Gupta, D. Kaushik, and O. Prakash, Eur. J. Med. Chem., 50, 81 (2012).

I. Shcherbakova, Khim. Geterotsikl. Soedin., 6 (2013). [Chem. Heterocycl. Compd., 49, 2 (2013)].

http://www.cerep.fr .

http://www.kinomescan.com .

P. Eleftheriou, A. Geronikaki, D. Hadjipavlou-Litina, P. Vicini, O. Filz, D. Filimonov, V. Poroikov, S. S. Chaudhaery, K. K. Roy, and A. Saxena, Eur. J. Med. Chem., 47, 111 (2012).

A. Lagunin, D. A. Filimonov, and V. V. Poroikov, Curr. Pharm. Des., 16, 1703 (2010).

J. Frearson and P. Wyatt, Expert Opin. Drug Discovery, 5, 909 (2010).

W. Rhodes, J. Transl. Med., 10 (Suppl. 2), A42 (2012).

D. M. Huryn, L. O. Resnick, and P. Wipf, J. Med. Chem., 56, 7161 (2013).

S. Ekins and B. A. Bunin, in: S. Cortagere (editor), In Silico Models for Drug Discovery, Series: Methods in Molecular Biology, Vol. 993, Humana Press, New York (2013), p. 139.